Pfizer is preparing to announce its second-quarter results.

Expectations from Pfizer and Market Performance

Pfizer (NYSE:PFE) is set to announce its earnings results this Tuesday before the market opens. In the last quarter, it achieved a revenue of 14.65 billion dollars, exceeding analysts' revenue expectations by %7.9. This marked a strong quarter for the company, reflecting a year-over-year increase of %10.3. Pfizer also exceeded analysts' organic revenue projections, showcasing an impressive performance.

Analysts are expecting that Pfizer's revenue in this quarter will decline by %6.2 year-over-year, dropping to 16.61 billion dollars; this is in contrast to a %31.2 increase recorded in the same quarter last year. Adjusted earnings per share are anticipated to be around 0.64 dollars.

Over the last 30 days, analysts reviewing the company have adjusted their forecasts generally, indicating that Pfizer will maintain a stable course leading up to their earnings announcement. However, Pfizer has missed Wall Street’s revenue expectations twice in the last two years.

Some of Pfizer's competitors in the branded pharmaceuticals segment have already announced their third-quarter results. Eli Lilly reported a revenue increase of %53.9 year-over-year, exceeding analyst expectations by %9.6. Bristol-Myers Squibb grew its revenues by %2.9, surpassing forecasts by %3.7. Following their results, Eli Lilly gained %6, while Bristol-Myers Squibb rose by %8.1.

Investors in the branded pharmaceuticals segment adopted a cautious stance as earnings reports approached, leading to a stagnant trend in stock prices over the past month. Conversely, Pfizer lost %6.7 in value during the same period and reported an average price target of 28.75 dollars, while its current stock price hovers around 24.67 dollars.

Today's young investors likely haven't read the timeless lessons of the book Gorilla Game: Picking Winners In High Technology, written 20 years ago when Microsoft and Apple established dominance. However, if we apply the same principles, it can be considered that corporate software stocks leveraging their generative AI capabilities might be the "gorilla" stocks of the future. In this context, we are pleased to offer our special free report on a profitable and rapidly growing corporate software stock that aims to capitalize on the automation wave and embrace generative AI.

StockStory is adding a stock analyst and marketing role to its growing team. Are you a builder with a passion for the markets and artificial intelligence? Check out the relevant link to see open positions.